Palliare Archives - Seroba Life Sciences

Palliare

U.S. FDA Grants 510(k) Expanded Indication for Palliare’s EVA15 Insufflation Technology to Accommodate Higher Pressure Range.

31 January 2023. Galway, Ireland and Oceanside, California, USA. Palliare, a leading developer of advanced insufflation technologies, has received an expanded 510(k) indication from the U.S. Food and Drug Administration for its EVA15 Insufflator to provide […]

Palliare announces US FDA 510(k) clearance to extend the indications of its EVA15 insufflation technology for use in endoscopic surgery.

Galway, Ireland. 15 July 2021. Seroba portfolio company, Palliare, an emerging company with the vision to create a safer operating room, has announced that it has received FDA 510(k) clearance for its END-200 tubeset, which extends […]

Seroba Leads $8M Series A Investment into Palliare

Galway, Ireland. 28 June 2021. Palliare, an emerging company with the vision to create a safer operating room, has announced the closing of an oversubscribed $8 million Series A funding round. The round was led by […]

Palliare

U.S. FDA Grants 510(k) Expanded Indication for Palliare’s EVA15 Insufflation Technology to Accommodate Higher Pressure Range.

Palliare announces US FDA 510(k) clearance to extend the indications of its EVA15 insufflation technology for use in endoscopic surgery.

Seroba Leads $8M Series A Investment into Palliare

Seroba Life Sciences 18 Herbert Street, Dublin 2

T: 353 (0)1 633 4028